MedPath

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia

Registration Number
NCT00003671
Lead Sponsor
Children's Oncology Group
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have newly diagnosed acute lymphocytic leukemia.

Detailed Description

OBJECTIVES: I. Determine whether a delayed multidrug intensification can be given in conjunction with methotrexate and leucovorin calcium rescue consolidation therapy in children with average risk acute lymphocytic leukemia. II. Determine the feasibility of delivering 6 courses of this therapy in these patients.

OUTLINE: This is a multicenter study. Induction: Patients receive oral dexamethasone twice daily on days 1-29, vincristine IV on days 1, 8, 15, and 22, and asparaginase intramuscularly (IM) on days 2, 5, 8, 12, 15, and 19. Patients receive methotrexate intrathecally (IT) on days 1 and 15. CNS 2 and 3 patients also receive methotrexate IT on days 8 and 22. Patients with M1 bone marrow receive oral mercaptopurine daily beginning on day 29. Patients with M2 bone marrow on day 29 receive oral dexamethasone twice daily on days 29-42, vincristine IV and daunorubicin IV over 15 minutes on days 29 and 36, and asparaginase IM on days 29, 32, 36, and 39. Patients with M3 bone marrow on day 29 or M2 or M3 bone marrow on day 43 are taken off study. Consolidation: Patients receive methotrexate IV over 4 hours once a week during weeks 7, 10, 13, 24, 27, and 30, oral leucovorin calcium every 6 hours for 5 doses beginning 42 hours after the start of methotrexate infusion, methotrexate IT during weeks 5, 9, 12, 16, 20, 21, and 29, asparaginase IM 3 times weekly during weeks 16 and 17, and oral mercaptopurine daily during weeks 5-14 and from week 24 until the end of consolidation. Patients receive oral dexamethasone twice daily during weeks 8, 16-18, and 28, vincristine IV on day 1 during weeks 8, 9, 16, 17, 18, 28, and 29, daunorubicin IV on day 1 during weeks 16, 17, and 18, cyclophosphamide IV over 30 minutes on day 1 during week 20, cytarabine IV or subcutaneously on days 2-5 during weeks 20 and 21, and oral thioguanine daily during weeks 20 and 21. Intensive continuation: Patients receive oral methotrexate every 6 hours for 24 hours during weeks 1, 3, 5, and 7, oral mercaptopurine daily, and oral leucovorin calcium every 12 hours for 1 day beginning 48 hours after the start of oral methotrexate. Patients also receive methotrexate IT during week 8, vincristine IV on day 1 during week 8, and oral dexamethasone twice daily for 7 days beginning with vincristine. Treatment repeats every 8 weeks for 6 courses. Another continuation: Patients receive oral methotrexate once weekly except during the week of methotrexate IT administration, oral mercaptopurine daily, methotrexate IT every 8 weeks, vincristine IV on day 1 during week 8, and oral dexamethasone twice daily for 7 days beginning with vincristine. Treatment continues for up to 130 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed every 6 months for 4 years and then annually for ten years.

PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study within 12 months.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
59
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Chemotherapy TreatmentdexamethasoneSee detailed description.
Chemotherapy Treatmentdaunorubicin hydrochlorideSee detailed description.
Chemotherapy Treatmentleucovorin calciumSee detailed description.
Chemotherapy Treatmentvincristine sulfateSee detailed description.
Chemotherapy TreatmentthioguanineSee detailed description.
Chemotherapy TreatmentasparaginaseSee detailed description.
Chemotherapy TreatmentcyclophosphamideSee detailed description.
Chemotherapy TreatmentcytarabineSee detailed description.
Chemotherapy TreatmentmercaptopurineSee detailed description.
Chemotherapy TreatmentmethotrexateSee detailed description.
Primary Outcome Measures
NameTimeMethod
Event-free survival7 years
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (57)

Cook Children's Medical Center - Fort Worth

πŸ‡ΊπŸ‡Έ

Fort Worth, Texas, United States

West Virginia University Hospitals

πŸ‡ΊπŸ‡Έ

Morgantown, West Virginia, United States

Madigan Army Medical Center

πŸ‡ΊπŸ‡Έ

Tacoma, Washington, United States

Montreal Children's Hospital

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Academisch Ziekenhuis Groningen

πŸ‡³πŸ‡±

Groningen, Netherlands

Children's Memorial Hospital, Chicago

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Eastern Maine Medical Center

πŸ‡ΊπŸ‡Έ

Bangor, Maine, United States

Maine Children's Cancer Program

πŸ‡ΊπŸ‡Έ

Portland, Maine, United States

Massachusetts General Hospital Cancer Center

πŸ‡ΊπŸ‡Έ

Boston, Massachusetts, United States

Simmons Cancer Center - Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

West Virginia University Medical School, Charleston Division

πŸ‡ΊπŸ‡Έ

Charleston, West Virginia, United States

Arizona Cancer Center

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Kaiser Permanente Medical Center - Santa Clara

πŸ‡ΊπŸ‡Έ

Santa Clara, California, United States

St. Mary's Hospital

πŸ‡ΊπŸ‡Έ

West Palm Beach, Florida, United States

Emory University Hospital - Atlanta

πŸ‡ΊπŸ‡Έ

Atlanta, Georgia, United States

Christ Hospital

πŸ‡ΊπŸ‡Έ

Oak Lawn, Illinois, United States

Via Christi Regional Medical Center-Saint Francis Campus

πŸ‡ΊπŸ‡Έ

Wichita, Kansas, United States

Keesler Medical Center - Keesler AFB

πŸ‡ΊπŸ‡Έ

Keesler AFB, Mississippi, United States

University of Missouri-Columbia Hospital and Clinics

πŸ‡ΊπŸ‡Έ

Columbia, Missouri, United States

Norris Cotton Cancer Center

πŸ‡ΊπŸ‡Έ

Lebanon, New Hampshire, United States

University of New Mexico School of Medicine

πŸ‡ΊπŸ‡Έ

Albuquerque, New Mexico, United States

State University of New York Health Sciences Center - Stony Brook

πŸ‡ΊπŸ‡Έ

Stony Brook, New York, United States

Kaiser Permanente-Southern California Permanente Medical Group

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

Naval Medical Center - San Diego

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

Lucile Packard Children's Hospital at Stanford

πŸ‡ΊπŸ‡Έ

Palo Alto, California, United States

Rush-Presbyterian-St. Luke's Medical Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Saint Jude Midwest Affiliate

πŸ‡ΊπŸ‡Έ

Peoria, Illinois, United States

Duke Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

Medical City Dallas Hospital

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Natalie Warren Bryant Cancer Center

πŸ‡ΊπŸ‡Έ

Tulsa, Oklahoma, United States

University of Texas Medical Branch

πŸ‡ΊπŸ‡Έ

Galveston, Texas, United States

Baylor College of Medicine

πŸ‡ΊπŸ‡Έ

Houston, Texas, United States

Scott and White Clinic

πŸ‡ΊπŸ‡Έ

Temple, Texas, United States

San Antonio Military Pediatric Cancer and Blood Disorders Center

πŸ‡ΊπŸ‡Έ

Lackland Air Force Base, Texas, United States

Inova Fairfax Hospital

πŸ‡ΊπŸ‡Έ

Falls Church, Virginia, United States

Washington University School of Medicine

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

St. John's Hospital and Medical Center

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Oklahoma Memorial Hospital

πŸ‡ΊπŸ‡Έ

Oklahoma City, Oklahoma, United States

Nemours Children's Clinic

πŸ‡ΊπŸ‡Έ

Jacksonville, Florida, United States

San Jorge Childrens Hospital

πŸ‡΅πŸ‡·

Santurce, Puerto Rico

Hurley Medical Center

πŸ‡ΊπŸ‡Έ

Flint, Michigan, United States

Baptist Hospital of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Centre Hospitalier de L'Universite Laval

πŸ‡¨πŸ‡¦

Sainte Foy, Quebec, Canada

St. Vincent Hospital

πŸ‡ΊπŸ‡Έ

Green Bay, Wisconsin, United States

Sylvester Cancer Center, University of Miami

πŸ‡ΊπŸ‡Έ

Miami, Florida, United States

Alberta Children's Hospital

πŸ‡¨πŸ‡¦

Calgary, Alberta, Canada

Children's Hospital of Eastern Ontario

πŸ‡¨πŸ‡¦

Ottawa, Ontario, Canada

Clinique de Pediatrie

πŸ‡¨πŸ‡­

Geneva, Switzerland

Vermont Cancer Center

πŸ‡ΊπŸ‡Έ

Burlington, Vermont, United States

James H. Quillen College of Medicine

πŸ‡ΊπŸ‡Έ

Johnson City, Tennessee, United States

University of Mississippi Medical Center

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Sutter Cancer Center

πŸ‡ΊπŸ‡Έ

Sacramento, California, United States

Walt Disney Memorial Cancer Institute

πŸ‡ΊπŸ‡Έ

Orlando, Florida, United States

Midwest Children's Cancer Center

πŸ‡ΊπŸ‡Έ

Milwaukee, Wisconsin, United States

Tulane University School of Medicine

πŸ‡ΊπŸ‡Έ

New Orleans, Louisiana, United States

Tripler Army Medical Center

πŸ‡ΊπŸ‡Έ

Honolulu, Hawaii, United States

Carilion Roanoke Memorial Hospital

πŸ‡ΊπŸ‡Έ

Roanoke, Virginia, United States

Β© Copyright 2025. All Rights Reserved by MedPath